Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 16.05.2022
Defence Therapeutics Inc.
Upcoming Investor Event:
Defense Therapeutics Inc. to present at digital International Investment
Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Defense Therapeutics Inc. will also present its business model and
current business development.
Presentation slot:
Defense Therapeutics Inc. (ISIN: CA24 [ … ]
Mon, 16.05.2022
Energiekontor AG
First Berlin Equity Research hat ein Research Update zu Energiekontor AG
(ISIN: DE0005313506) veröffentlicht. Analyst Dr. Karsten von Blumenthal
stuft die Aktie auf BUY herauf aber senkt das Kursziel von EUR 105,00 auf
EUR 103,00.
Zusammenfassung:
Energiekontor (EKT) hat ihren Q1-Zwischenbericht veröffentlicht, der einen
qualitativen & [ … ]
Sat, 14.05.2022
Cardiol Therapeutics Inc.
Upcoming Investor Event:
Cardiol Therapeutics Inc. to present at digital International Investment
Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Cardiol Therapeutics Inc. will also present its business model and
current business development.
Presentation slot:
Cardiol Therapeutics Inc. (ISIN: CA14 [ … ]
Fri, 13.05.2022
Aspermont Ltd.
Upcoming Investor Event:
Aspermont to present at digital International Investment Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Aspermont Ltd. will also present its business model and current
business development.
Presentation slot:
Aspermont Ltd. (ISIN: AU000000ASP3)
04.00 am EST (New York, To [ … ]
Thu, 12.05.2022
Knaus Tabbert AG
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG
(ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 87,00.
Zusammenfassung:
Die Dreimonatsergebnisse lagen nahe an unseren Schätzungen und
erwartungsgemäß unter den Vorja [ … ]
Thu, 12.05.2022
PNE AG
First Berlin Equity Research hat ein Research Update zu PNE AG (ISIN:
DE000A0JBPG2) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt
seine REDUCE-Empfehlung und erhöht das Kursziel von EUR 11,50 auf EUR
12,00.
Zusammenfassung:
PNE hat dank der herausragenden Leistung ihres Stromerzeugung-Segments
hervorragende Q1-Zahle [ … ]
Thu, 12.05.2022
CENIT AG
Q1 2022: Revenues slightly up, earnings slightly down year-on-year;
inorganic effects not yet included; we confirm our forecasts; price target
changes due to higher WACC; BUY rating confirmed
The seasonal sales trend of CENIT AG is usually characterised by lower
sales revenues in the first quarter, while the fourth quarter makes the
largest cont [ … ]
Mon, 09.05.2022
Ikonisys SA
New significant shareholder through convertible bond
With the issuance of a de facto mandatory convertible bond, Ikonisys has,
in our view, found a smart solution to one of its major problems: Funding
the market entry of Ikoniscope20 in the US and Europe and funding the
further development of the microscope platform into a state-of-the-art
artif [ … ]
Mon, 09.05.2022
Kleos Space S.A.
First Berlin Equity Research has published a research update on Kleos Space
S.A. (ISIN: AU0000015588). Analyst Christian Orquera reiterated his BUY
rating and maintained his AUD 2.60 price target.
Abstract:
Kleos Space SA (Kleos) has published its Q1 2022 financial and business
update. The company achieved revenues of €107k (AUD 167k). The [ … ]
Mon, 09.05.2022
Aspermont Ltd.
Q2-2022 preliminary report shows increased growth
The following are some of the company's highlights:
- Total revenue +39% at $4.8m
- Gross profit +43% at $3.1m, with gross margins of 65% versus 63%
- Earnings +20% at $0.5m on a normalized basis
- Dean Felton joined the Aspermont board
- Aspermont returned to live events with Future of [ … ]